Key result
Low-carbohydrate diet linked to ~11-mmHg systolic BP reduction at 2 years despite less medication.
Cohort (n=154)
No
Answers are grounded in this paper and cite their sources.
Hypertension is the second biggest known global risk factor for disease after poor diet; perhaps lifestyle interventions are underutilized? In a previous small pilot study, it was found that a low carbohydrate diet was associated with significant improvements in blood pressure, weight, ‘deprescribing’ of medications and lipid profiles. We were interested to investigate if these results would be replicated in a larger study based in ‘real world’ GP practice. 154 patients with type 2 diabetes or impaired glucose tolerance were recruited into an observational cohort study in primary care. The effects of a low carbohydrate diet sustained for an average of two years (interquartile range 10–32 months) on cardiovascular risk factors were examined. Results demonstrate significant and substantial reductions in blood pressure (mean reduction of systolic BP 10.9 mmHg (interquartile range 0–22 mmHg) (p < 0.0001), mean reduction in diastolic BP 6.3 mmHg (interquartile range 0–12.8 mmHg) (p < 0.0001) and mean weight reduction of 9.5 Kg (interquartile range 5–13 Kg) (p < 0.0001) together with marked improvement in lipid profiles. This occurred despite a 20% reduction in anti-hypertensive medications. This novel and potentially highly effective dietary modification, done very cheaply alongside routine care, offers hope that should be tested in a large prospective trial.
No takes yet. Share an insight, caveat, or question.
Unwin et al. (2019) conducted a cohort in Type 2 diabetes or impaired glucose tolerance (n=154). Low carbohydrate diet was evaluated on Reduction in systolic blood pressure, diastolic blood pressure, weight, and lipid profiles (Mean systolic BP reduction 10.9 mmHg, diastolic BP reduction 6.3 mmHg, weight reduction 9.5 kg, p=<0.0001). A low carbohydrate diet for an average of 2 years reduced systolic BP by 10.9 mmHg, diastolic BP by 6.3 mmHg, and weight by 9.5 kg (all p<0.0001) despite a 20% reduction in antihypertensives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: